Dose-Related and Time-Dependent Development of Collagenase-Induced Tendinopathy in Rats
Overview
Authors
Affiliations
Tendinopathy is a big burden in clinics and it represents 45% of musculoskeletal lesions. Despite the relevant social impact, both pathogenesis and development of the tendinopathy are still under-investigated, thus limiting the therapeutic advancement in this field. The purpose of this study was to evaluate the dose-dependent and time-related tissue-level changes occurring in a collagenase-induced tendinopathy in rat Achilles tendons, in order to establish a standardized model for future pre-clinical studies. With this purpose, 40 Sprague Dawley rats were randomly divided into two groups, treated by injecting collagenase type I within the Achilles tendon at 1 mg/mL (low dose) or 3 mg/mL (high dose). Tendon explants were histologically evaluated at 3, 7, 15, 30 and 45 days. Our results revealed that both the collagenase doses induced a disorganization of collagen fibers and increased the number of rounded resident cells. In particular, the high dose treatment determined a greater neovascularization and fatty degeneration with respect to the lower dose. These changes were found to be time-dependent and to resemble the features of human tendinopathy. Indeed, in our series, the acute phase occurred from day 3 to day 15, and then progressed towards the proliferative phase from day 30 to day 45 displaying a degenerative appearance associated with a very precocious and mild remodeling process. The model represents a good balance between similarity with histological features of human tendinopathy and feasibility, in terms of tendon size to create lesions and costs when compared to other animal models. Moreover, this model could contribute to improve the knowledge in this field, and it could be useful to properly design further pre-clinical studies to test innovative treatments for tendinopathy.
Treatment options for Achilles tendinopathy: a scoping review of preclinical studies.
Agyeman-Prempeh N, Maas H, Burchell G, Millar N, Moen M, Smit T PeerJ. 2025; 13():e18143.
PMID: 39807157 PMC: 11727660. DOI: 10.7717/peerj.18143.
Torretta E, Moriggi M, Capitanio D, Perucca Orfei C, Raffo V, Setti S Int J Mol Sci. 2024; 25(16).
PMID: 39201538 PMC: 11354614. DOI: 10.3390/ijms25168852.
Kurtulmus T, Celebi M, Bektas E, Arican C, Kucukyildirim B, Demirkol M Acta Orthop Traumatol Turc. 2024; 58(2):102-109.
PMID: 39128059 PMC: 11181225. DOI: 10.5152/j.aott.2024.23157.
Cellular and Structural Changes in Achilles and Patellar Tendinopathies: A Pilot In Vivo Study.
Kouroupis D, Perucca Orfei C, Correa D, Talo G, Libonati F, De Luca P Biomedicines. 2024; 12(5).
PMID: 38790957 PMC: 11117798. DOI: 10.3390/biomedicines12050995.
Antioxidant and anti-inflammatory injectable hydrogel microspheres for treatment of tendinopathy.
Han Q, Bai L, Qian Y, Zhang X, Wang J, Zhou J Regen Biomater. 2024; 11:rbae007.
PMID: 38414798 PMC: 10898336. DOI: 10.1093/rb/rbae007.